Dulce María Román Romero
Research Subjects
Dulce María Román Romero has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Vargas Oliva
Instituto Mexicano del Seguro Social
1 shared publication - David Antonio Ramírez Pérez
Instituto Tecnologico y de Estudios Superiores de Monterrey
1 shared publication - Gisela Berenice Orozco Torres
Instituto Mexicano del Seguro Social
1 shared publication - Marco Alejandro Nezahualcóyotl León Cardoso
Instituto Mexicano del Seguro Social
1 shared publication
Latest Publications
- Open Access
- 18 October 2025
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 4 (4) , 4616-4627
Asociación de la No Adherencia al Tratamiento en Pacientes con Hipertensión Arterial Sistémica y el Deterioro Cognitivo en Adultos Mayores de 65 Años
Background. Aging population has increased the prevalence of chronic diseases such as systemic arterial hypertension (SAH), especially in older adults. One of the main challenges in its management is achieving adequate adherence to treatment, with various factors involved, including cognitive impairment. This condition affects functions such as memory, judgment, and comprehension, negatively impacting the patient's ability to follow therapeutic instructions. Given this context, it is considered important to analyze whether there is a relationship between non-adherence and cognitive impairment. Objective. To establish the association between non-adherence to antihypertensive treatment and cognitive impairment in adults over 65 years of age. Materials and methods. An analytical cross-sectional study was conducted in 193 hypertensive patients over 65 years of age. A non-probabilistic convenience sampling method was used. Adherence was assessed using the 8-item Morisky scale (MMAS-8), and cognitive status was assessed using the Mini-Mental State Examination (MMSE). Descriptive statistics and bivariate analysis using the Chi-square test (p<0.05) were applied. Results: 49.7% of patients were non-adherent to treatment. Among them, 30% presented cognitive impairment, compared to 14% in the adherent group (p=0.006). The prevalence of comorbidities was high, with diabetes mellitus (36.6%) and dyslipidemia (6.7%) being the most prominent. Conclusion: A statistically significant association was identified between non-adherence to treatment and cognitive impairment. These findings support the need to incorporate cognitive screening into the care of hypertensive older adults to improve adherence and clinical outcomes.
- 18 October 2025
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 4 (4) , 4616-4627
Open AccessAsociación de la No Adherencia al Tratamiento en Pacientes con Hipertensión Arterial Sistémica y el Deterioro Cognitivo en Adultos Mayores de 65 Años
Background. Aging population has increased the prevalence of chronic diseases such as systemic arterial hypertension (SAH), especially in older adults. One of the main challenges in its management is achieving adequate adherence to treatment, with various factors involved, including cognitive impairment. This condition affects functions such as memory, judgment, and comprehension, negatively impacting the patient's ability to follow therapeutic instructions. Given this context, it is considered important to analyze whether there is a relationship between non-adherence and cognitive impairment. Objective. To establish the association between non-adherence to antihypertensive treatment and cognitive impairment in adults over 65 years of age. Materials and methods. An analytical cross-sectional study was conducted in 193 hypertensive patients over 65 years of age. A non-probabilistic convenience sampling method was used. Adherence was assessed using the 8-item Morisky scale (MMAS-8), and cognitive status was assessed using the Mini-Mental State Examination (MMSE). Descriptive statistics and bivariate analysis using the Chi-square test (p<0.05) were applied. Results: 49.7% of patients were non-adherent to treatment. Among them, 30% presented cognitive impairment, compared to 14% in the adherent group (p=0.006). The prevalence of comorbidities was high, with diabetes mellitus (36.6%) and dyslipidemia (6.7%) being the most prominent. Conclusion: A statistically significant association was identified between non-adherence to treatment and cognitive impairment. These findings support the need to incorporate cognitive screening into the care of hypertensive older adults to improve adherence and clinical outcomes.